Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial
about
An alternative treatment of hyperlipidemia with red yeast rice: a case report.A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemiaCardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter.Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia.Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo.Disease Prevention and Health Promotion: How Integrative Medicine Fits.Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of LovastatinThe role of red yeast rice for the physician.Red yeast rice for the treatment of dyslipidemia.Systematic review of red yeast rice compared with simvastatin in dyslipidaemia.Functional foods and dietary supplements for the management of dyslipidaemia.Assessment of monacolin in the fermented products using Monascus purpureus FTC5391"When diet and exercise are not enough": an examination of lifestyle change inefficacy claims in direct-to-consumer advertising.A Walnut-Enriched Diet Reduces Lipids in Healthy Caucasian Subjects, Independent of Recommended Macronutrient Replacement and Time Point of Consumption: a Prospective, Randomized, Controlled Trial.Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol.Hypocholesterolemic activity of monascus fermented product in the absence of monacolins with partial purification for functional food applications
P2860
Q33663590-9F07A158-9910-4DFE-BF1A-BDF2F3895CE5Q33711391-10DDA34D-1CDD-443E-82DD-538B7258996EQ34183882-9DA57939-F9EA-4991-8AB1-87C76D64DCD1Q34199028-28583DB2-A4F9-407A-A09F-FF13C6E33668Q34984106-C2E56545-11DA-4377-98B1-0457BCBADF2BQ36191041-B3E85F4E-52F7-4C24-934D-8A0BD10329F4Q36444037-BD574EB5-7330-404F-94D6-05C219DF5DBBQ37808130-95BF362A-9CCF-4EB2-8ECE-9F43FBC0C407Q38366473-66467AAD-CCF0-4FC3-8CD0-F4F247137886Q38766010-04E151E8-2B4B-4DCF-8984-E367CDB2127BQ39108473-F0591D92-D97B-487F-A34A-011CC7A7BC74Q39532984-27980DC3-D507-47C8-BA55-ADFF04D7812DQ44808297-3205519E-6FB8-42A0-8D19-92E25A1CCC01Q45985992-A5180B74-8BD2-4095-9AE4-FC866FE94DA2Q47118074-87320E87-D5FB-4FF4-82BD-DA76F5DEFDE6Q59075140-6CFC4382-7F4A-4122-ACCB-3BE22B6B994F
P2860
Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@ast
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@en
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@nl
type
label
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@ast
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@en
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@nl
prefLabel
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@ast
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@en
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@nl
P2093
P356
P1476
Simvastatin vs therapeutic lif ...... mized primary prevention trial
@en
P2093
David J Becker
Jacqueline Yorko
Mingyao Li
Nayyar Iqbal
Patti B Morris
Ram Y Gordon
Y Jerold Gordon
P304
P356
10.4065/83.7.758
P407
P577
2008-07-01T00:00:00Z